Perceptive Introduces Clinical Adjudication Services to Enhance Data Integrity in Trials

Perceptive Introduces Clinical Adjudication Services to Enhance Data Integrity in Trials
Supporting sponsors’ critical trial milestones with confidence
Perceptive, a global leader in discovery, imaging, and eClinical solutions, today announced the launch of its Clinical Adjudication Services, providing sponsors with independent review of trial event assessments. As the biopharmaceutical and investigational device industries face increasing demands to deliver faster results while upholding the highest standards of data integrity, Perceptive’s services offer the precision, quality, and support needed to help sponsors meet critical milestones with confidence.
“Perceptive’s Clinical Adjudication Services underscore our commitment to delivering unmatched support in clinical trials, providing the reliability and transparency sponsors need to confidently navigate the complexities of drug development.” said David Herron, CEO of Perceptive.
Led by Craig McLendon, who brings more than 25 years of clinical adjudication experience, Perceptive Clinical Adjudication provides comprehensive support across therapeutic areas, drawing on a team that has managed the adjudication of over 600,000 events and a network of more than 250 global experts and key opinion leaders (KOLs). The team includes dedicated adjudication project managers who serve as a single point of contact for sponsors, overseeing the entire process across the US, APAC, and Europe.
“Our Clinical Adjudication Services are built to provide the efficient, unbiased event assessment that today’s trials demand,” said McLendon. “For example, in clinical trials investigating antibody drug conjugates (ADCs) for the treatment of cancers, regulatory agencies around the world are asking sponsors to monitor for drug-induced Interstitial Lung Disease (ILD). By leveraging our deep expertise and extensive global network, we can help sponsors confidently assess these and other risks, ensuring patient safety and enabling smarter decision-making for our clients.”
Perceptive is committed to supporting all clinical adjudication needs, including subject eligibility, digital pathology, independent review, and committees for safety events and adverse events of special interest. To help clients meet critical trial milestones, expedited adjudication timelines are available upon request, delivering faster results without compromising on quality or regulatory compliance.
Click here for more information about Perceptive’s Clinical Adjudication Services.
About Perceptive
Perceptive is a leading global technology-enabled service provider of preclinical and clinical trial imaging, clinical event adjudication, and IRT/RTSM (Interactive Response Technology/Randomized Trial Supply Management) for drug developers and the global clinical research community. Perceptive’s market-leading service, scientific knowledge, expertise, and technology offering help speed up the delivery of life-saving treatments to millions of patients around the world by accelerating and improving clinical trial outcomes. With operations in the US, Europe, the UK and Asia, the company provides 24/7 services to most of the world’s leading pharma and biotech companies.
Follow Perceptive on LinkedIn.